Hoda M Rabea

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Diffusion Weighted Imaging

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Sahar H Elhini, Engy A Wahsh, Ahmed A Elberry, Nadia F El Ameen, Ahmed Abdelfadil Saedii, Shereen Mahmoud Refaie, Asmaa A Elsayed, Hoda M Rabea
The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Sahar H Elhini, Engy A Wahsh, Ahmed A Elberry, Nadia F El Ameen, Ahmed Abdelfadil Saedii, Shereen Mahmoud Refaie, Asmaa A Elsayed, Hoda M Rabea
The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Sahar H Elhini, Engy A Wahsh, Ahmed A Elberry, Nadia F El Ameen, Ahmed Abdelfadil Saedii, Shereen Mahmoud Refaie, Asmaa A Elsayed, Hoda M Rabea
The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Sahar H Elhini, Engy A Wahsh, Ahmed A Elberry, Nadia F El Ameen, Ahmed Abdelfadil Saedii, Shereen Mahmoud Refaie, Asmaa A Elsayed, Hoda M Rabea
The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Sahar H Elhini, Engy A Wahsh, Ahmed A Elberry, Nadia F El Ameen, Ahmed Abdelfadil Saedii, Shereen Mahmoud Refaie, Asmaa A Elsayed, Hoda M Rabea
The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)